A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation - PRAISE-Study
Latest Information Update: 03 Mar 2022
Price :
$35 *
At a glance
- Drugs Iloprost (Primary)
- Indications Ischaemia; Thrombosis
- Focus Pharmacodynamics
- Acronyms PRAISE
- 03 Mar 2022 Status changed to discontinued.(End date of the trial:2014-12-11).
- 27 Feb 2016 Status changed from recruiting to completed as reported by ISRCTN record.
- 16 Jul 2012 Trial design presented at the 24th International Congress of the Transplantation Society.